Differences in the target specificity of the transactivating factors MHBst and HBx of hepatitis B virus

References

1. Angel P., Imagawa M., Chiu R., Stein B., Imbra R. J., Rahmsdorf H. J., Jonat C., Herrlich P., Karin M. 1987; Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 49:729–739
   [Google Scholar]
2. Arii M., Takada S., Koike K. 1992; Identification of three essential regions of hepatitis B virus X protein for trans-activation function. Oncogene 7:397–403
   [Google Scholar]
3. Beasley R. P. 1988; Hepatitis B virus: the major etiology of hepatocellular carcinoma. Cancer 61:1942–1956
   [Google Scholar]
4. Caselmann W. H., Meyer M., Kekulé A. S., Lauer U., Hofschneider P. H., Koshy R. 1990; A transactivator function is generated by integration of hepatitis B virus preS/S sequences in human hepatocellular carcinoma. Proceedings of the National Academy of Sciences, USA 87:2970–2974
   [Google Scholar]
5. Chang R. S. 1954; Continuous subcultivation of epithelial-like cells from normal human tissues. Proceedings of the Society of Ex perimental Biology and Medicine 87:440–443
   [Google Scholar]
6. Davidson I., Xiao J. H., Rosales R., Staub A., Chambon P. 1988; The HeLa cell protein TEF-1 binds specifically and cooperatively to two SV40 enhancer motifs of unrelated sequence. Cell 54:931–942
   [Google Scholar]
7. Fromental C., Kanno M., Nomiyama H., Chambon P. 1988; Cooperativity and hierarchical levels of functional organization in the SV40 enhancer. Cell 54:943–953
   [Google Scholar]
8. Ganem D., Varmus H. E. 1987; The molecular biology of the hepatitis B viruses. Annual Reviews in Biochemistry 56:651–693
   [Google Scholar]
9. IsHiji T., Lace M. J., Parkinnen S., Anderson R. D., Haugen T. H., Cripe T. P., Xiao J.-H., Davidson I., Chambon P., Turek L. P. 1992; Transcriptional enhancer factor (TEF-1) and its cell-specific co-activator activate human papillomavirus-16 E6 and E7 oncogene transcription in keratinocytes and cervical carcinoma cells. EMBO Journal 11:2271–2281
   [Google Scholar]
10. Kanno M., Fromental C., Staub A., Ruffenach F., Davidson I., Chambon P. 1989; The SV40 TC-II(kB) and the related H-2K^B enhansons exhibit different cell type specific and inducible proto enhancer activities, but the SV40 core sequence and the AP-2 binding site have no enhanson properties. EMBO Journal 8:4205–4215
    [Google Scholar]
11. Kekulé A. S., Lauer U., Meyer M., Caselmann W. H., Hofschneider P. H., Koshy R. 1990; The preS2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator. Nature 343:457–461
    [Google Scholar]
12. Kekulé A. S., Lauer U., Weiss L., Luber B., Hofschneider P. H. 1993; Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway. Nature 361:742–745
    [Google Scholar]
13. Kim Y.-H., Kang S.-K., Lee Y. I. 1993; Functional analysis of the hepatitis B virus transactivator X: implication of the leucine zipper like region and C-terminal seven conserved amino acids in functional regions. Biochemical and Biophysical Research Communications 197:894–903
    [Google Scholar]
14. Koch W., Benoist C., Mathis D. 1989; Anatomy of a new B-cell-specific enhancer. Molecular and Cellular Biology 9:303–311
    [Google Scholar]
15. Koshy R., Meyer M. 1992; Oncogenicity of hepatitis B virus. Reviews in Medical Virology 2:131–140
    [Google Scholar]
16. Kwee L., Lucito R., Aufiero B., Schneider R. J. 1992; Alternate translation initiation on hepatitis B virus X mRNA produces multiple polypeptides that differentially transactivate class II and III promoters. Journal of Virology 66:4382–4389
    [Google Scholar]
17. Lauer U., Weiss L., Hofschneider P. H., Kekulé A. S. 1992; The hepatitis B virus pre-S/S′ transactivator is generated by 3′ truncations within a defined region of the S gene. Journal of Virology 66:5284–5289
    [Google Scholar]
18. Lee W., Haslinger A., Karin M., Than R. 1987; Activation of transcription by two factors that bind promoter and enhancer sequences of the human metallothionein gene and SV40. Nature 325:368–372
    [Google Scholar]
19. Luber B., Bürgelt E., Fromental C., Kanno M., Koch W. 1991; Multiple simian virus 40 enhancer elements mediate the trans-activating function of the X protein of hepatitis B virus. Virology 184:808–813
    [Google Scholar]
20. Macchi M., Bornert J.-M., Davidson I., Kanno M., Rosales R., Vigneron M., Xiao J.-H., Fromental C., Chambon P. 1989; The SV40 TC-II (kB) enhanson binds ubiquitous and cell type specifically inducible nuclear proteins from lymphoid and non lymphoid cell lines. EMBO Journal 8:4215–4227
    [Google Scholar]
21. Maguire H. F., Hoefler J. P., Siddiqui A. 1991; HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions. Science 252:842–844
    [Google Scholar]
22. Meyer M., Caselmann W. H., Schluter V., Schreck R., Hof schneider P. H., Baeuerle P. A. 1992; Hepatitis B virus transactivator MHBs¹: activation of NF-kB, selective inhibition by antioxidants and integral membrane localization. EMBO Journal 11:2991–3001
    [Google Scholar]
23. Mitchell P. J., Wang C., Than R. 1987; Positive and negative regulation of transcription in vitro: enhancer-binding protein AP-2 is inhibited by SV40 T antigen. Cell 50:847–861
    [Google Scholar]
24. Nomiyama H., Fromental C., Xiao J. H., Chambon P. 1987; Cell-specific activity of the constituent elements of the simian virus 40 enhancer. Proceedings of the National Academy of Sciences, USA 84:7881–7885
    [Google Scholar]
25. Renner M., Haniel A., Bürgelt E., Hofschneider P. H., Koch W. 1995; Transactivating function and expression of the x gene of hepatitis B virus. Journal of Hepatology (in press)
    [Google Scholar]
26. Ritter S. E., Whitten T. M., Quets A. T., Schloemer R. H. 1991; An internal domain of the hepatitis B virus X antigen is necessary for transactivating activity. Virology 182:841–845
    [Google Scholar]
27. Rosales R., Vigneron M., Macchi M., Davidson I., Xiao J. H., Chambon P. 1987; In vitro binding of cell-specific and ubiquitous nuclear proteins to the octamer motif of the SV40 enhancer and related motifs present in other promoters and enhancers. EMBO Journal 6:3015–3025
    [Google Scholar]
28. Seto E., Mitchell P. J., Yen T. S. B. 1990; Transactivation by the hepatitis B virus X protein depends on AP-2 and other transcription factors. Nature 344:72–74
    [Google Scholar]
29. Tiollais P., Pourcel C., Dejean A. 1985; The hepatitis B virus. Nature 317:489–195
    [Google Scholar]
30. Tooze J. 1982; DNA tumor viruses. In Molecular Biology of Tumor Viruses 2nd edn., part 2, revised New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
31. Twu J.-S., Schloemer R. H. 1987; Transcriptional transactivating function of hepatitis B virus. Journal of Virology 61:3448–3453
    [Google Scholar]
32. Wollersheim M., Debelka U., Hofschneider P. H. 1988; A transactivating function encoded in the hepatitis B virus X gene is conserved in the integrated state. Oncogene 3:545–552
    [Google Scholar]
33. Xiao J. H., Davidson I., Matthes H., Garnier J.-M., Chambon P. 1991; Cloning, expression, and transcriptional properties of the human enhancer factor TEF-1. Cell 65:551–568
    [Google Scholar]
34. Zahm P., Hofschneider P. H., Koshy R. 1988; The HBV X-ORF encodes a transactivator: a potential factor in viral hepato-carcinogenesis. Oncogene 3:169–177
    [Google Scholar]
35. Zenke M., Grundström T., Matthes H., Wintzerith M., Schatz C., Wildeman A., Chambon P. 1986; Multiple sequence motifs are involved in SV40 enhancer function. EMBO Journal 5:387–397
    [Google Scholar]